| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507885 | Acta Pharmaceutica Sinica B | 2018 | 10 Pages |
Abstract
Mangiferin aglycon derivative J99745 possessed potent xanthine oxidase (XOD) inhibition in vitro. In hyperuricemic mice, J99745 reduced serum urate and MDA content, enhanced fractional excretion of uric acid, and attenuated kidney damage. J99745 might represent a promising antihyperuricemia agent by inhibiting XOD activity and urate transporter 1 expression.183
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Zhizhen Qin, Shoubao Wang, Yihuang Lin, Ying Zhao, Shengqian Yang, Junke Song, Tao Xie, Jinlong Tian, Song Wu, Guanhua Du,